SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination
21 Mar, 2021 | 22:02h | UTCSARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies – Cell
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies – Cell